These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers. Shah VM; Tandon R; Satpathy G; Nayak N; Chawla B; Agarwal T; Sharma N; Titiyal JS; Vajpayee RB Cornea; 2010 Jul; 29(7):751-7. PubMed ID: 20489580 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group. O'Brien TP; Maguire MG; Fink NE; Alfonso E; McDonnell P Arch Ophthalmol; 1995 Oct; 113(10):1257-65. PubMed ID: 7575256 [TBL] [Abstract][Full Text] [Related]
5. Fluoroquinolones or fortified antibiotics for treating bacterial keratitis: systematic review and meta-analysis of comparative studies. Hanet MS; Jamart J; Chaves AP Can J Ophthalmol; 2012 Dec; 47(6):493-9. PubMed ID: 23217502 [TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis. Hyon JY; Joo MJ; Hose S; Sinha D; Dick JD; O'Brien TP Arch Ophthalmol; 2004 Aug; 122(8):1166-9. PubMed ID: 15302657 [TBL] [Abstract][Full Text] [Related]
7. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis. Panda A; Ahuja R; Sastry SS Eye (Lond); 1999 Dec; 13 ( Pt 6)():744-7. PubMed ID: 10707137 [TBL] [Abstract][Full Text] [Related]
9. Fluoroquinolones in the treatment of bacterial keratitis. Bower KS; Kowalski RP; Gordon YJ Am J Ophthalmol; 1996 Jun; 121(6):712-5. PubMed ID: 8644818 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of fortified antibiotics and fluoroquinolones for the treatment of bacterial keratitis: A meta-analysis. Zhou R; Wang Q; Yuan L; Zhou H; Xue J J Fr Ophtalmol; 2024 May; 47(5):103940. PubMed ID: 37741755 [TBL] [Abstract][Full Text] [Related]
11. Monotherapy versus fortified antibiotics for bacterial keratitis. Rosenberg JB; Gritz DC Cornea; 2011 Sep; 30(9):1066; author reply 1066-7. PubMed ID: 21775886 [No Abstract] [Full Text] [Related]
12. Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial. Sharma N; Goel M; Bansal S; Agarwal P; Titiyal JS; Upadhyaya AD; Vajpayee RB Ophthalmology; 2013 Jun; 120(6):1173-8. PubMed ID: 23415776 [TBL] [Abstract][Full Text] [Related]
14. Clinical Features, Antibiotic Susceptibility Profile, and Outcomes of Infectious Keratitis Caused by Stenotrophomonas maltophilia. Palioura S; Gibbons A; Miller D; OʼBrien TP; Alfonso EC; Spierer O Cornea; 2018 Mar; 37(3):326-330. PubMed ID: 29408828 [TBL] [Abstract][Full Text] [Related]
15. Use of Topical Besifloxacin in the Treatment of Mycobacterium chelonae Ocular Surface Infections. Nguyen AT; Hong AR; Baqai J; Lubniewski AJ; Huang AJ Cornea; 2015 Aug; 34(8):967-71. PubMed ID: 26075451 [TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial. Constantinou M; Daniell M; Snibson GR; Vu HT; Taylor HR Ophthalmology; 2007 Sep; 114(9):1622-9. PubMed ID: 17822972 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of sparfloxacin eye drop in the management of conjunctival and corneal infection. Vyas U; Desai T; Shah C J Indian Med Assoc; 2002 Jun; 100(6):398-9. PubMed ID: 12416674 [TBL] [Abstract][Full Text] [Related]